![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 487/04 | |
A61K 31/4184 | |||
A61P 35/00 |
(11) | Number of the document | 2217603 |
(13) | Kind of document | T |
(96) | European patent application number | 08837011.9 |
Date of filing the European patent application | 2008-10-10 | |
(97) | Date of publication of the European application | 2010-08-18 |
(45) | Date of publication and mention of the grant of the patent | 2015-11-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2008/079439 |
Date | 2008-10-10 |
(87) | Number | WO 2009/049109 |
Date | 2009-04-16 |
(30) | Number | Date | Country code |
979654 P | 2007-10-12 | US |
(72) |
ZHU, Guidong, US
|
(73) |
AbbVie Bahamas Ltd.,
Sassoon House Shirley Street & Victoria Avenue, New Providence, Nassau,
BS
|
(54) | 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 2 |
2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 2 |